Entries by

ALLEA Launches New Task Force to Investigate the Intellectual Property System for New Genomic Techniques

When considering the potential of New Genomic Techniques, such as genome editing using the CRISPR-Cas technology, the protection of intellectual property rights is a critical concern. To address these issues in support of a more equitable system, ALLEA has established a dedicated Task Force consisting of some of Europe’s leading experts on the topic.